SECsense Logo

Bellevue Life Sciences Acquisition Corp. 8-K Report: Key Securities Insights

$BLAC
Form 8-K
Filed on: 2024-12-23
Source
Bellevue Life Sciences Acquisition Corp. 8-K Report: Key Securities Insights

Here are the key insights extracted from the provided financial report section:

  1. Entity Identification: The report pertains to Bellevue Life Sciences Acquisition Corp., with SEC CIK number 0001840425.
  2. Reporting Date: The financial data is reported for December 17, 2024.
  3. Securities Offered:
  • Units: Each unit consists of:
    • One share of common stock
    • One redeemable warrant
    • One right to receive one-tenth (1/10) of one share of common stock
  • Common Stock: Identified as having a par value of $0.0001 per share.
  • Redeemable Warrants: These are exercisable for shares of common stock at an exercise price of $11.50 per share.
  1. Stock and Warrant Symbols:
  • Common Stock: BLAC (NASDAQ)
  • Redeemable Warrants: BLACW (NASDAQ)
  • Rights to Receive Shares: BLACR (NASDAQ)
  1. Contact Information: The company is located at 10900 NE 4th Street, Suite 2300, Bellevue, WA 98004, and the contact number is (425) 635-7700.
  2. Regulatory Filing: The document is associated with an 8-K filing, which is typically used to report major events that shareholders should know about.
  3. Key Classes of Stock: The report lists explicit members under the US GAAP classification for the types of stock, including:
  • Units consisting of common stock, redeemable warrants, and rights.
  • Common stock.
  • Redeemable warrants.
  • Rights to receive a fraction of a share of common stock.

This information provides a snapshot of the company's securities and their structure, which is crucial for investors and analysts evaluating Bellevue Life Sciences Acquisition Corp.